Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 967

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 6
Chunk 967
---
 director
nominees, (iii) each of our executive officers, and (iv) all of our named executive officers and directors as a group. As of such date,
we had 2,585,316 shares of our common stock issued and outstanding, after adjustment for the 1-for-8 reverse stock split effective as
of the close of business on June 6, 2025 with an effective trading date of June 9, 2025. We believe that each individual or entity named
has sole investment and voting power with respect to shares of common stock indicated as beneficially owned by them, subject to community
property laws where applicable, except where otherwise noted.

Unless otherwise indicated,
the address for each person listed in the table below is c/o Aethlon Medical, Inc., 11555 Sorrento Valley Road, Suite 203, San Diego,
CA 92121.

    NAME OF BENEFICIAL OWNER 
    NUMBER OF SHARES BENEFICIALLY OWNED(1)  
    PERCENT OF SHARES BENEFICIALLY OWNED(2) 
  
    Greater than 5% Stockholders 

    Armistice Capital, LLC 
     180,758(3) 
     7% 
  
    Ikarian Capital, LLC 
     153,660(4) 
     6% 
  
    Directors and Named Executive Officers 

    James B. Frakes, Chief Executive Officer, Chief Financial Officer and Director 
     2,805(5) 
     * 
  
    Edward G. Broenniman, Chairman and Director 
     4,887(6) 
     * 
  
    Chetan S. Shah, M.D., Director 
     3,923(7) 
     * 
  
    Angela Rossetti, Director 
     6,208(8) 
     * 
  
    Steven P. LaRosa, M.D., Chief Medical Officer 
     2,552(9) 
     * 
  
    Nicolas Gikakis, Director 
     3,569(10) 
     – 
  
    All Current Directors and Executive Officers as a Group (6 members) 
     23,944  
     9% 

____________________

    *
    Less than 1%

    (1)
    Calculated pursuant to Rule 13d-3(d)(1) of the Exchange Act. Under Rule 13d-